Organic Active Ingredients TRIZ Cases

A monovalent metal salt of alginic acid composition combined with concentrated bone marrow aspirate restores hyaline cartilage tissue.

Mutated FGF1 analogs activate FGFR1 signaling to lower blood glucose and improve insulin sensitivity without triggering mitogenic activity.

Specific ingredient proportions in the dietary supplement resolve formulation complexity while enhancing long-term immunity and addressing oxidative stress.

Perlecan domain V reduces lesion size by interacting with alpha5beta1 integrin, avoiding early pathology exacerbation.

Incorporating lysolipids into nanolipoprotein particles increases the mass ratio of loaded hydrophobic molecules while maintaining lipid bilayer integrity.

Steroselective thiazolidinedione analogs deliver insulin sensitizing activity via mitochondrial pathways.

Mixed melting point fats solubilize ubidecarenone into needle-shaped crystals, preventing amorphous aggregation that lowers bioavailability.

Topical vitamin D3 analog increases systemic regulatory T cell levels, reducing hypercalcemia risk from oral dosing.

Substituted oxopyridine derivatives inhibit factor XIa, reducing thrombus formation while minimizing bleeding risk.

Bifunctional compounds link a target protein binding moiety to an E3 ubiquitin ligase binding moiety for targeted degradation.

Merges oxytocin with autonomic agents to enhance sexual response while reducing side effects from single therapies.

Applying a low-pH niacinamide composition reduces S100-A7 protein levels to alleviate psoriasis symptoms.

Combining an anti-Tau antibody with an O-GlcNAcase inhibitor targets tau pathology through synergistic clearance and prevention mechanisms.

A two-portion solution system creates a voluminous, water-insoluble cross-linked hydrogel mass in the stomach to reduce food intake without adverse effects.

Novel glucocorticoid compounds utilize a 17α furoate group to enhance receptor affinity, reducing adverse side effects while overcoming resistance.

A feed additive combines probiotics, enzymes, and adsorbents to improve nutrient absorption in pets.

A solid pharmaceutical composition uses silica and guar flour to form a viscous solution upon dissolution in water.

Solubilized keratin compositions induce substantial vasodilation to expand blood vessel diameter and improve cardiac contractility.

Amphiphilic block polymer functionalized transition metal dichalcogenide nanosheets scavenge reactive oxygen species.

Liquid melphalan hydrochloride formulation with solvents and antioxidants eliminates lyophilization reconstitution time while maintaining stability.

Lipid carriers shield dronedarone from intestinal pH variations, resolving low aqueous solubility and poor bioavailability.

A nanofibrous wound dressing combines photocurable and hydrophobized hyaluronic acid derivatives to form a stable, mechanically resistant structure.

Pyridazine derivatives inhibit ALK fusion proteins to overcome treatment resistance in cancers.

ARM-U2 compounds bind uPAR receptors to recruit endogenous antibodies, resolving the trade-off between late-stage efficacy and systemic toxicity.

Characterizing novel solid forms of compound 1 via XRPD resolves the complexity of selecting polymorphs for stable fatty acid synthase inhibitors.

Ternary supramolecular system prevents precipitation by forming stable complexes with succinic acid and panthenol.

Aromatic dipeptides self-assemble into hydrogel nanoparticles, eliminating complex synthesis and hazardous chemicals to improve biocompatibility.

Specific indole and indazole structures activate AMPK, addressing the lack of effective metabolic regulators in diabetes treatments.

Formula I quinoxaline compounds inhibit tyrosine and serine/threonine kinases to treat cancers like melanoma.

Human milk oligosaccharides bind to coronavirus particles, blocking attachment to host ACE2 receptors to attenuate respiratory inflammation.

Repurposed acetylcholinesterase inhibitor pyridostigmine reduces mechanical ventilation needs and mortality by suppressing pro-inflammatory cytokines.

Merging dispersion and suspension steps in one reactor eliminates complex multi-reactor equipment while maintaining thixotropic rheological properties.

A veterinary pharmaceutical composition uses a binder and adsorbent to create palatable tablets with adequate hardness.

Modified siRNA sequences enhance serum stability and reduce off-target effects while inhibiting GST-π expression in malignant tumors.

Combining zotarolimus and paclitaxel on a single stent reduces neointimal hyperplasia while managing manufacturing complexity.

Purifying bergamot extracts to remove furocoumarins eliminates toxicity while maintaining hypolipidemic efficacy against hepatic steatosis.

Dexpramipexole removes eosinophil support to overcome drug resistance and reduce plasma cell proliferation in multiple myeloma.

CRISPR/Cas9 gene editing corrects CFTR mutations, restoring ion channel function and reducing mucous viscosity.

A pharmaceutical composition combining citric acid, magnesium citrate, phytin, pyridoxine, and musa inhibits calcium oxalate crystal growth.

A nasal chlorogenic acid composition uses absorption enhancers to improve bioavailability and blood-brain barrier penetration.

Conjugating C22 hydrocarbon chains to internal positions on dsRNA agents enables efficient delivery to muscle and adipose tissues.

Pulsatile GnRH administration restores natural hormonal rhythms to normalize food intake, avoiding adverse effects of conventional obesity medications.

Effervescent agents lower gastric pH and generate carbon dioxide, enabling rapid dissolution of high-concentration active ingredients.

An ADAM9 inhibitor overcomes the immunosuppressive tumor microenvironment by stimulating immune cell infiltration and cytokine secretion.

An adhesive patch utilizes oxybuprocaine as an absorption promoter to maintain high piroxicam release without salt formation inhibiting drug delivery.

A peptide with sequence AQTGTGKT binds to CAGE protein and inhibits its inter-linkage with GSK3β.

Local polymeric proanthocyanidin composition inhibits COX-2 in the intestine, avoiding systemic cardiovascular side effects from conventional inhibitors.

Segmented wax-coated topiramate granules within a binder matrix resolve the contradiction between tablet hardness and rapid dispersion time.

PLGA microparticles deliver verteporfin and CB-839 to reverse vascular remodeling in pulmonary hypertension.